Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
复制标题
DOI:
10.1084/jem.20050067
复制
发表时间:
2005-07-04
期刊:
影响因子:
--
通讯作者:
Nerlov C
中科院分区:
文献类型:
--
作者:
Porse BT;Bryder D;Theilgaard-Mönch K;Hasemann MS;Anderson K;Damgaard I;Jacobsen SE;Nerlov C
CCAAT/enhancer binding protein (C/EBP)α is a myeloid-specific transcription factor that couples lineage commitment to terminal differentiation and cell cycle arrest, and is found mutated in 9% of patients who have acute myeloid leukemia (AML). We previously showed that mutations which dissociate the ability of C/EBPα to block cell cycle progression through E2F inhibition from its function as a transcriptional activator impair the in vivo development of the neutrophil granulocyte and adipose lineages. We now show that such mutations increase the capacity of bone marrow (BM) myeloid progenitors to proliferate, and predispose mice to a granulocytic myeloproliferative disorder and transformation of the myeloid compartment of the BM. Both of these phenotypes were transplantable into lethally irradiated recipients. BM transformation was characterized by a block in granulocyte differentiation, accumulation of myeloblasts and promyelocytes, and expansion of myeloid progenitor populations—all characteristics of AML. Circulating myeloblasts and hepatic leukocyte infiltration were observed, but thrombocytopenia, anemia, and elevated leukocyte count—normally associated with AML—were absent. These results show that disrupting the cell cycle regulatory function of C/EBPα is sufficient to initiate AML-like transformation of the granulocytic lineage, but only partially the peripheral pathology of AML.
登录
查看更多内容
DOI:
10.1073/pnas.94.10.5302
发表时间:
1997-05-13
影响因子:
11.1
作者:
He, LZ;Tribioli, C;Pandolfi, PP
通讯作者:
Pandolfi, PP
DOI:
10.1084/jem.194.7.941
发表时间:
2001-10-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bryder D;Ramsfjell V;Dybedal I;Theilgaard-Mönch K;Högerkorp CM;Adolfsson J;Borge OJ;Jacobsen SE
通讯作者:
Jacobsen SE
影响因子:
20.3
作者:
D'Alo, F;Johansen, LM;Tenen, DG
通讯作者:
Tenen, DG
影响因子:
11.4
作者:
Kaeferstein, A;Krug, U;Verbeek, W
通讯作者:
Verbeek, W
影响因子:
64.8
作者:
Hock, H;Hamblen, MJ;Orkin, SH
通讯作者:
Orkin, SH